drug summary · 2 NDC codes
Livmarli 9.5 mg/mL
maralixibat chloride
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | maralixibat chloride |
|---|---|
| active ingredients | MARALIXIBAT CHLORIDE |
| dosage form | SOLUTION |
| route | ORAL |
| strength | 9.5 mg/mL |
| marketing status | NDA |
| DEA schedule | not reported |
| application number | NDA214662 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | Mirum Pharmaceuticals Inc. |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | Ileal Bile Acid Transporter Inhibitor [EPC]; Ileal Bile Acid Transporter Inhibitors [MoA]; Organic Anion Transporting Polypeptide 2B1 Inhibitors [MoA] |
NDC codes
2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 79378-110 | — |
| 79378011001 | — |
Other maralixibat chloride products
5 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.
- Livmarli 10 mg/1TABLET · Mirum Pharmaceuticals Inc.
- Livmarli 15 mg/1TABLET · Mirum Pharmaceuticals Inc.
- Livmarli 19 mg/mLSOLUTION · Mirum Pharmaceuticals Inc.
- Livmarli 20 mg/1TABLET · Mirum Pharmaceuticals Inc.
- Livmarli 30 mg/1TABLET · Mirum Pharmaceuticals Inc.
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.